home / stock / sght / sght news

SGHT News and Press, Sight Sciences Inc. From 10/24/23

Stock Information
Company Name: Sight Sciences Inc.
Stock Symbol: SGHT
Market: NASDAQ
Website: sightsciences.com
Menu
SGHT SGHT Quote SGHT Short SGHT News SGHT Articles SGHT Message Board
Get SGHT Alerts

News, Short Squeeze, Breakout and More Instantly...
SGHT - Sight Sciences to Report Third Quarter 2023 Financial Results on November 7, 2023

MENLO PARK, Calif., Oct. 24, 2023 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (“Sight Sciences,” or the “Company”), an eyecare technology company focused on developing and commercializing innovative technology intended to transform care and improve patients...
SGHT - Sight Sciences to Host SAHARA 6 Month RCT Results Reception at the American Academy of Ophthalmology 2023

MENLO PARK, Calif., Oct. 19, 2023 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (“Sight Sciences,” or the “Company”), an eyecare technology company focused on developing and commercializing innovative technology intended to transform care and improve patients...

SGHT - Sight Sciences Announces Presentation of Successful Phase I Results of the SAHARA Randomized Controlled Clinical Trial Comparing TearCare® to Restasis® for the Treatment of Dry Eye Disease at the American Academy of Optometry Annual Meeting

MENLO PARK, Calif., Oct. 12, 2023 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (“Sight Sciences,” or the “Company”), an eyecare technology company focused on developing and commercializing innovative technology intended to transform care and improve patients...

SGHT - Sight Sciences Announces New, Large-Scale MIGS Data from 41st Congress of ESCRS Demonstrating TCOR(TM) Using OMNI® Surgical System Technology is Effective at Lowering Both IOP and IOP Reducing Medications at 2 Years in Patients with Glaucoma

MENLO PARK, Calif., Oct. 03, 2023 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (“Sight Sciences”), an eyecare technology company focused on developing and commercializing innovative technology intended to transform care and improve patients’ lives, today announced ...
SGHT - BofA Securities: Which small cap non-earner stocks to avoid

2023-09-20 11:55:57 ET More on Health Care Sector: Seeking Alpha’s Quant Rating on Health Care Select Sector SPDR Health Care Select Sector SPDR ETF declares quarterly distribution of $0.5395 BofA clients were net buyers of U.S. equities for a fifth consecutiv...

SGHT - Piper Sandler cuts Sight Sciences to neutral, cites lowered guidance

2023-09-12 17:41:30 ET More on Sight Sciences Seeking Alpha’s Quant Rating on Sight Sciences Historical earnings data for Sight Sciences Financial information for Sight Sciences Sight Sciences: Staying Bullish After Q2 Results Beat Sight Scienc...

SGHT - SLGG, VERB and MYO among mid-day movers

2023-09-12 12:52:44 ET Gainers: Anebulo Pharmaceuticals ( ANEB ) +35% . WeWork ( WE ) +34% . Shengfeng Development Limited ( SFWL ) +29% . AEON Biopharma ( AEON ) +28% . Avalo Therapeutics ( AVTX ) +28% . The Beauty Health Co...
SGHT - Investigation of Sight Sciences, Inc. (SGHT) Announced by Holzer & Holzer, LLC

ATLANTA, Sept. 12, 2023 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC is investigating whether Sight Sciences, Inc. (“Sight Sciences” or “the Company”) (NASDAQ: SGHT) complied with federal securities laws. On September 11, 2023, Sight Sciences announced its third quarte...

SGHT - CGC, BLRX and WHLR among pre-market losers

2023-09-12 08:42:44 ET Losers: Acelyrin ( SLRN ) -56% announces top-line results from placebo-controlled clinical trial of Izokibep for moderate-to-severe Hidradenitis Suppurativa. Sight Sciences ( SGHT ) -31% on updated guidance . Super League Gaming (...

SGHT - Biggest stock movers today: WestRock, Oracle and more

2023-09-12 06:14:55 ET Related stories Compare metrics for HUMA to ORCL, SGHT, SLRN, WRK WestRock: Solid Asset-Based, But (Likely) Not The Right Time Reevaluating Acelyrin: The Impact Of Mixed Izokibep Results (Rating Downgrade) Oracle Corporation ( ORCL ...
Previous 10 Next 10